Cargando…
P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430979/ http://dx.doi.org/10.1097/01.HS9.0000970404.32161.f4 |
| _version_ | 1785091089501257728 |
|---|---|
| author | Bugge Askeland, Frida Haukås, Einar Slørdahl, Tobias S. Klostergaard, Anja Alexandersen, Tatjana Schjøll, Diana Lysén, Anna Hermansen, Emil Schjesvold, Fredrik |
| author_facet | Bugge Askeland, Frida Haukås, Einar Slørdahl, Tobias S. Klostergaard, Anja Alexandersen, Tatjana Schjøll, Diana Lysén, Anna Hermansen, Emil Schjesvold, Fredrik |
| author_sort | Bugge Askeland, Frida |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430979 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309792023-08-17 P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY Bugge Askeland, Frida Haukås, Einar Slørdahl, Tobias S. Klostergaard, Anja Alexandersen, Tatjana Schjøll, Diana Lysén, Anna Hermansen, Emil Schjesvold, Fredrik Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430979/ http://dx.doi.org/10.1097/01.HS9.0000970404.32161.f4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bugge Askeland, Frida Haukås, Einar Slørdahl, Tobias S. Klostergaard, Anja Alexandersen, Tatjana Schjøll, Diana Lysén, Anna Hermansen, Emil Schjesvold, Fredrik P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY |
| title | P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY |
| title_full | P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY |
| title_fullStr | P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY |
| title_full_unstemmed | P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY |
| title_short | P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY |
| title_sort | p875: replacing steroids in transplant-ineligible multiple myeloma: the phase 2 isatuximab-bortezomib-lenalidomide-dexamethasone rest study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430979/ http://dx.doi.org/10.1097/01.HS9.0000970404.32161.f4 |
| work_keys_str_mv | AT buggeaskelandfrida p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT haukaseinar p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT slørdahltobiass p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT klostergaardanja p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT alexandersentatjana p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT schjølldiana p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT lysenanna p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT hermansenemil p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy AT schjesvoldfredrik p875replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy |